Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]

Syed Hasan Shuja, Farea Eqbal, Hafsa Rehman Dow Medical College, Karachi, Sindh, PakistanCorrespondence: Syed Hasan ShujaDow Medical College, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, 74200, PakistanTel +923200250770Email hasanshuja6@gmail.com View the original paper by Dr Fraile...

Full description

Saved in:
Bibliographic Details
Published in:Drug design, development and therapy development and therapy, 2021-01, Vol.15, p.4227-4228
Main Authors: Shuja, Syed Hasan, Eqbal, Farea, Rehman, Hafsa
Format: Article
Language:English
Subjects:
Dapagliflozin
Health aspects
Letter
n/a since it's an lte
Pharmaceutical industry
Type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Syed Hasan Shuja, Farea Eqbal, Hafsa Rehman Dow Medical College, Karachi, Sindh, PakistanCorrespondence: Syed Hasan ShujaDow Medical College, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, 74200, PakistanTel +923200250770Email hasanshuja6@gmail.com View the original paper by Dr Fraile and colleagues
ISSN:1177-8881
1177-8881
DOI:10.2147/DDDT.S341223